2025-10-20 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the provided data, presented as a report:

**Procter & Gamble (PG) Stock Analysis**

**1.  Performance Overview**

*   **Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation focused on providing branded consumer packaged goods to consumers across the world.
*   **Cumulative Return vs. S&P 500 (VOO):**
    *   PG Cumulative Return: 31.74%
    *   VOO Cumulative Return: 97.05%
    *   Return Disparity: -65.3%
    *   Relative Disparity: 3.9% (PG's performance is near the lower end of its historical range compared to VOO).
*   **Analysis:** PG has significantly underperformed the S&P 500 over the period for which cumulative returns are calculated. The relative disparity suggests this underperformance is not unusual, but rather consistent with historical trends.

*   **Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD     | Alpha    | Beta   | Cap(B) |
|------------|---------|---------|----------|--------|--------|
| 2015-2017  | 21.0%   | 7.9%    | -8.0%    | 0.0    | 215.0  |
| 2016-2018  | 9.0%    | 67.3%   | -6.0%    | 0.1    | 215.1  |
| 2017-2019  | 24.0%   | 70.4%   | 2.0%     | 0.3    | 292.3  |
| 2018-2020  | 27.0%   | 78.8%   | 4.0%     | 0.4    | 325.7  |
| 2019-2021  | 41.0%   | 78.8%   | -5.0%    | 0.5    | 382.9  |
| 2020-2022  | 13.0%   | 79.4%   | 13.0%    | 0.6    | 354.7  |
| 2021-2023  | 26.0%   | 79.4%   | 24.0%    | 0.4    | 343.0  |
| 2022-2024  | 9.0%    | 79.4%   | -12.0%   | 0.4    | 392.4  |
| 2023-2025  | -12.0%  | 80.1%   | -74.0%   | 0.2    | 354.4  |

*   **Analysis:**
    *   **CAGR:** The Compound Annual Growth Rate (CAGR) shows varying growth patterns. The most recent period (2023-2025) shows a negative CAGR of -12.0%.
    *   **MDD:** High Maximum Drawdown (MDD) values indicate significant potential losses from peak to trough.
    *   **Alpha:** The Alpha values indicate the stock's performance relative to the market. Negative Alpha values, especially in the most recent period (-74.0%), suggest significant underperformance compared to the market.
    *   **Beta:** The Beta values are relatively low, suggesting that the stock is less volatile than the market.

**2. Recent Stock Price Trends**

*   **Current Price:** $151.40
*   **Previous Close:** $149.60
*   **Change:** $1.20 (Recent price increase)
*   **Moving Averages:**
    *   5-day MA: 149.01
    *   20-day MA: 151.28
    *   60-day MA: 154.58

*   **Analysis:** The stock price is currently above both its 5-day and 20-day moving averages, which could be seen as a short-term bullish signal. However, it remains below the 60-day moving average, suggesting potential resistance at that level. The positive change compared to the previous close supports a short-term upward trend. The recent price increase of $1.20 is not extreme, so there are no significant volatility issues to consider.

**3.  Market Risk Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment Recommended)
*   **RSI:** 43.30 (Neutral, neither overbought nor oversold)
*   **PPO:** -0.0139 (Slightly bearish)
*   **Hybrid Signal:** Buy 100% of cash (7 shares - Very Safe - MRI:0.90). Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Recent (20-day) Relative Disparity Change:** -2.0 (Short-term decline in relative performance)
*   **Expected Return:** 61.7% (Long-term, relative to S&P 500)

*   **Analysis:**
    *   The MRI suggests a low investment recommendation, which indicates caution given the current market conditions.
    *   The RSI is neutral, indicating the stock is not currently overbought or oversold.
    *   The negative PPO hints at potential short-term weakness.
    *   The hybrid signal suggests a buying strategy based on a safe asset allocation model.
    *   The negative change in relative disparity reflects recent underperformance relative to the S&P 500.
    *   The high expected return suggests potential for long-term outperformance if a dollar-cost averaging approach is applied.

**4. Recent News & Significant Events**

*   **Key Headlines:**
    *   Tesla, Netflix earnings watch (Yahoo Finance)
    *   Jim Cramer says Kimberly-Clark could be bottoming (Insider Monkey)
    *   Colgate Stock as an antidote to AI-Dominated Markets (Barrons.com)

*   **Analysis:**
    *   The news focuses more on broader market trends (Tesla, Netflix, inflation) than specific P&G news.
    *   The mention of Kimberly-Clark (a competitor) potentially bottoming suggests possible sector-wide recovery sentiment.
    *   The article on Colgate as a safe haven in AI-dominated markets indicates a preference for stable, established consumer staples companies during volatile times. This could indirectly benefit P&G as well.

**4.2 Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 2.04 (Approximately Buy)
*   **Number of Opinions:** 22
*   **Target Price:**
    *   Average: $169.09
    *   High: $186.00
    *   Low: $147.00
*   **Recent Rating Changes:** No specific changes provided.

*   **Analysis:** Analyst consensus is generally positive, with a "Buy" rating and a target price significantly above the current price. This suggests analysts see upside potential for the stock.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-04-24 | 1.58 | $19.78B   |
| 2025-01-22 | 1.94 | $21.88B   |
| 2024-10-18 | 1.65 | $21.74B   |
| 2024-04-19 | 1.56 | $20.20B   |
| 2025-04-24 | 1.56 | $20.20B   |

*   **Analysis:**
    *   The earnings data shows some fluctuation in both EPS (Earnings Per Share) and revenue.
    *   The revenue has been relatively stable, hovering between $19.78B and $21.88B.
    *   The EPS also shows some variability, but generally remains positive.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $20.89B    | 49.11%        |
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |
| 2024-06-30   | $20.53B    | 49.60%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-06-30   | $52.01B    | 6.95%     |
| 2025-03-31   | $52.27B    | 7.21%     |
| 2024-12-31   | $51.17B    | 9.05%     |
| 2024-09-30   | $51.84B    | 7.64%     |
| 2024-06-30   | $50.29B    | 6.24%     |

*   **Analysis:**
    *   **Revenue:** Revenue has remained relatively stable over the past few quarters.
    *   **Profit Margin:** Profit margins are consistently high, indicating efficient cost management and strong pricing power.
    *   **Equity:** Equity has shown a gradual increase over time.
    *   **ROE (Return on Equity):** ROE fluctuates, but overall indicates the company is effectively generating profits from shareholders' investments.

**7. Overall Assessment**

Procter & Gamble is a stable, mature company with strong financials and a history of consistent profitability. However, it has significantly underperformed the broader market (S&P 500) in recent times.

*   **Strengths:**
    *   Strong brand portfolio and global reach
    *   High profit margins
    *   Relatively stable revenue and earnings
    *   Positive analyst consensus
*   **Weaknesses:**
    *   Underperformance relative to the S&P 500
    *   Low growth potential compared to tech or growth sectors
    *   Relatively low market risk indicator (MRI)

**Investment Recommendation:**

Based on the analysis, a cautious investment approach is recommended. While P&G offers stability and consistent profitability, its underperformance relative to the market and the low MRI suggest that investors should consider their risk tolerance and investment goals. A long-term, dollar-cost averaging approach might be suitable, especially given the positive long-term return expectations, but investors should be aware of the potential for continued underperformance compared to the broader market. The hybrid signal supports a buying strategy based on a safe asset allocation model.
